The joint-gut axis in inflammatory bowel diseases
JOURNAL OF CROHNS & COLITIS (2010)
期刊
JOURNAL OF CROHNS & COLITIS
卷 4, 期 3, 页码 257-268出版社
OXFORD UNIV PRESS
关键词
作者
我是这篇论文的作者
推荐
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease
Jurij Hanzel, Christopher Ma, Niels Vande Casteele, Reena Khanna, Vipul Jairath, Brian G. Feagan
DRUGS (2021)
Prevalence of Extraintestinal Manifestations in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Yakup Kilic, Shahed Kamal, Farah Jaffar, Danujan Sriranganathan, Mohammed Nabil Quraishi, Jonathan P. Segal
INFLAMMATORY BOWEL DISEASES (2023)
Temporal Relationship of Extraintestinal Manifestations in Inflammatory Bowel Disease
Istvan Fedor, Eva Zold, Zsolt Barta
JOURNAL OF CLINICAL MEDICINE (2021)
Tofacitinib for extraintestinal manifestations of inflammatory bowel disease: A literature review
Yuanzhuo Wang, Ziqi Wan, Rui Jin, Tianming Xu, Yan Ouyang, Baihui Wang, Gechong Ruan, Xiaoyin Bai
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
Extraintestinal Manifestations of Inflammatory Bowel Disease: Current Concepts, Treatment, and Implications for Disease Management
Gerhard Rogler, Abha Singh, Arthur Kavanaugh, David T. Rubin
GASTROENTEROLOGY (2021)
Dermatological Manifestations in Inflammatory Bowel Diseases
Elisabetta Antonelli, Gabrio Bassotti, Marta Tramontana, Katharina Hansel, Luca Stingeni, Sandro Ardizzone, Giovanni Genovese, Angelo Valerio Marzano, Giovanni Maconi
JOURNAL OF CLINICAL MEDICINE (2021)
Roles of microRNAs in inflammatory bowel disease
HyunTaek Jung, Jae Seok Kim, Keum Hwa Lee, Kalthoum Tizaoui, Salvatore Terrazzino, Sarah Cargnin, Lee Smith, Ai Koyanagi, Louis Jacob, Han Li, Sung Hwi Hong, Dong Keon Yon, Seung Won Lee, Min Seo Kim, Paul Wasuwanich, Wikrom Karnsakul, Jae Il Shin, Andreas Kronbichler
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Clinical Features Focusing on Extraintestinal Manifestations in Japanese Patients with Inflammatory Bowel Diseases: Far East 1000
Yuki Ohta, Takashi Taida, Jun Kato, Sadahisa Ogasawara, Yuhei Oyama, Yukiyo Mamiya, Hayato Nakazawa, Ryosuke Horio, Chihiro Goto, Satsuki Takahashi, Akane Kurosugi, Michiko Sonoda, Wataru Shiratori, Tatsuya Kaneko, Yuya Yokoyama, Naoki Akizue, Hideaki Ishigami, Hirotaka Koseki, Kenichiro Okimoto, Keiko Saito, Masaya Saito, Tomoaki Matsumura, Tomoo Nakagawa, Yoshio Masuya, Yoshihiro Fukuda, Yoshio Kitsukawa, Haruhisa Shimura, Toshio Tsuyuguchi, Naoya Kato
DIGESTION (2023)
Therapeutic Implications of Diet in Inflammatory Bowel Disease and Related Immune-Mediated Inflammatory Diseases
Yan Jiang, Karolin Jarr, Cosima Layton, Christopher D. Gardner, Judith E. Ashouri, Maria T. Abreu, Sidhartha R. Sinha
NUTRIENTS (2021)
Influence of systemic manifestations of inflammatory bowel diseases on endothelial function and cardiovascular risk
Mariabeatrice Principi, Pietro Scicchitano, Sonia Carparelli, Rosa Nitti, Roberta Ruggieri, Maria C. Bellino, Annagrazia Cecere, Fabio Manca, Alfredo Di Leo, Marco M. Ciccone
MINERVA MEDICA (2022)
Vaccines in Children with Inflammatory Bowel Disease: Brief Review
Susanna Esposito, Giulia Antoniol, Marialuisa Labate, Lucrezia Passadore, Patrizia Alvisi, Valeria Dacco, Chiara Ghizzi, Carla Colombo, Nicola Principi
VACCINES (2021)
Solid extraintestinal malignancies in patients with inflammatory bowel disease
Anastasia Mala, Kalliopi Foteinogiannopoulou, Ioannis E. Koutroubakis
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
Extra-Intestinal Manifestations of Inflammatory Bowel Disease
Aliya H. Sange, Natasha Srinivas, Mubashira K. Sarnaik, Srimy Modi, Yasaswi Pisipati, Sarayoo Vaidya, Naqvi Syed Gaggatur, Ibrahim Sange
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Helminth Lessons in Inflammatory Bowel Diseases (IBD)
Tyler Atagozli, David E. Elliott, Mirac Nedim Ince
BIOMEDICINES (2023)
Extraintestinal manifestations of inflammatory bowel disease, nitroxidative stress and dysbiosis: What is the link between them?
Amylly Sanuelly Da Paz Martins, Samara Bomfim Gomes Campos, Marilia Oliveira Fonseca Goulart, Fabiana Andrea Moura
BIOCELL (2021)
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B. M. Landewe, Sofia Ramiro, Desiree van der Heijde, Elena Nikiphorou
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis
Augusta Ortolan, Casper Webers, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B. M. Landewe, Sofia Ramiro, Desiree van der Heijde, Elena Nikiphorou
ANNALS OF THE RHEUMATIC DISEASES (2023)
External validation of the alternative Ankylosing Spondylitis Disease Activity Score in three randomized clinical trials of ixekizumab
Augusta Ortolan, Sofia Ramiro, Roberta Ramonda, Desiree van der Heijde
RHEUMATOLOGY (2023)
Treating spondyloarthritis early: does it matter? Results from a systematic literature review
Dafne Capelusnik, Diego Benavent, Desiree van der Heijde, Robert Landewe, Denis Poddubnyy, Astrid van Tubergen, Louise Falzon, Victoria Navarro-Compan, Sofia Ramiro
RHEUMATOLOGY (2023)
The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
Casper Webers, Uta Kiltz, Juergen Braun, Desiree van der Heijde, Annelies Boonen
RHEUMATOLOGY (2023)
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
Desiree van der Heijde, Atul Deodhar, Xenofon Baraliakos, Matthew A. Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M. Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S. Gensler, Nigil Haroon, Marina Magrey, Walter P. Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip van den Bosch, Thomas Vaux, Huji Xu
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S. Smolen, Desiree van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E. Pope, Tsutomu Takeuchi, Kimme L. Hyrich, Kevin L. Winthrop, Daniel Aletaha, Tanja A. Stamm, Jan W. Schoones, Robert B. M. Landewe
ANNALS OF THE RHEUMATIC DISEASES (2023)
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S. Smolen, Desiree van der Heijde, Roberto Caporali, Christopher J. Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme Hyrich, Kevin L. Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Robert B. M. Landewe
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Desiree van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E. Pope, Tsutomu Takeuchi, Kimme L. Hyrich, Kevin L. Winthrop, Daniel Aletaha, Tanja A. Stamm, Jan W. Schoones, Josef S. Smolen, Robert B. M. Landewe
ANNALS OF THE RHEUMATIC DISEASES (2023)
Response to: Correspondence on ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update by Ramiro et al
Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B. M. Landewe, Desiree van der Heijde
ANNALS OF THE RHEUMATIC DISEASES (2023)
ASAS consensus definition of early axial spondyloarthritis
Victoria Navarro-Compan, Diego Benavent, Dafne Capelusnik, Desiree van der Heijde, Robert B. M. Landewe, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip E. van den Bosch, Floris A. van Gaalen, Lianne Gensler, Clementina Lopez-Medina, Helena Marzo-Ortega, Anna Molto, Rodolfo Perez-Alamino, Martin Rudwaleit, Marleen van de Sande, Raj Sengupta, Ulrich Weber, Sofia Ramiro
ANNALS OF THE RHEUMATIC DISEASES (2023)
Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program (Feb, 10.3899/jrheum.221022, 2023)
Atul Deodhar, Denis Poddubnyy, Proton Rahman, Jeorg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araujo, Ann Leung, Desiree van der Heijde
JOURNAL OF RHEUMATOLOGY (2023)
Robust analyses for radiographic progression in rheumatoid arthritis
Robert Landewe, Luna Sun, Yun-Fei Chen, Daojun Mo, Desiree van der Heijde
RMD OPEN (2023)
Bimekizumab treatment in patients with active axial spondyloarthritis: 52-week efficacy and safety from the randomised parallel phase 3 BE MOBILE 1 and BE MOBILE 2 studies
Xenofon Baraliakos, Atul Deodhar, Desiree van der Heijde, Marina Magrey, Walter P. Maksymowych, Tetsuya Tomita, Huji Xu, Ute Massow, Carmen Fleurinck, Alicia M. Ellis, Thomas Vaux, Julie Shepherd-Smith, Alexander Marten, Lianne S. Gensler
ANNALS OF THE RHEUMATIC DISEASES (2023)
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trial
Rosalinde Stal, Sofia Ramiro, Desiree van der Heijde, Floris A. van Gaalen, Xenofon Baraliakos, Pedro M. Machado, Manouk de Hooge, Rosaline van den Berg, Monique Reijnierse, Juergen Braun, Robert Landewe, Alexandre Sepriano
RMD OPEN (2023)